SC
ENTX icon

Steven Cohen’s Entera Bio ENTX Stock Holding History

Steven Cohen’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,382
Closed -$13.7K – 4168
2026
Q1 		$13.7K Sell
12,382
-1,181,271
-99% -$1.66M ﹤0.01% 3693
2025
Q4 		$2.32M Buy
1,193,653
+15,210
+1% +$35.7K ﹤0.01% 2379
2025
Q3 		$2.26M Sell
1,178,443
-1,518,793
-56% -$2.91M ﹤0.01% 1389
2025
Q2 		$5.12M Hold
2,697,236
– – 0.01% 962
2025
Q1 		$4.59M Buy
+2,697,236
New +$5.87M 0.01% 956

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Steven Cohen's ENTX Position: Q2 2026 in Review

Steven Cohen sold out of Entera Bio (ENTX) in Q2 2026, closing a stake of 12,382 shares — an estimated $13.7K sold.

Steven Cohen first reported a position in ENTX in Q1 2025 and held it in 5 quarters. The position peaked at $5.12M in Q2 2025. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Steven Cohen reported no remaining Entera Bio position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 12,382 Entera Bio shares in Q2 2026, an estimated $13.7K.
  • Steven Cohen first reported a position in Entera Bio in Q1 2025 and held it in 5 quarters.
  • Steven Cohen's Entera Bio position peaked at $5.12M in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.